Labcorp Drug Development revenue

Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.

Labcorp Drug Development revenue increased from $4.6 billion in 2019 to $4.9 billion in 2020, a (6.5%) increase.

Labcorp Drug Development revenue was $4.88 b in FY, 2020 which is a (6.5%) year over year increase from the previous period.

	FY, 2017	FY, 2018	FY, 2019	FY, 2020
Revenue	$3.04 b	$4.31 b	$4.58 b	$4.88 b
Growth		42.01%	6.14%	6.54%

	Q1, 2018	Q2, 2018	Q3, 2018	Q1, 2019	Q2, 2019	Q3, 2019	Q1, 2020	Q2, 2020	Q3, 2020
Revenue	$1.08 b	$1.05 b	$1.08 b	$1.07 b	$1.13 b	$1.18 b	$1.14 b	$1.09 b	$1.24 b

Need Data?

Craft can deliver 250+ data points of financial, operating, and human capital indicators on companies via API.